Skip to Main Content

Author Details

Mar??a J Garc??a
Spanish National Cancer Research Centre (CNIO)
1996
74
29
PMIDPaper TitleJournal TitlePublished Year
37536268Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients.Inflamm Bowel Dis2024
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37369443Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.Can J Surg2023
34864927Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.J Crohns Colitis2022
35437272Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer.Int J Gynecol Cancer2022
35640971CNpare: matching DNA copy number profiles.Bioinformatics2022
35053516CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival.Cancers (Basel)2022
32969471Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.J Crohns Colitis2021
34406676Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study).Aliment Pharmacol Ther2021
34640421Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu.J Clin Med2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
32181930Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease.Aliment Pharmacol Ther2020
31909414Crohn's Disease and Immunosupressive Treatment: Hepatosplenic Lesions as an Atypical Case of Bartonella henselae.Inflamm Bowel Dis2020
32723069Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.United European Gastroenterol J2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
31063540Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.J Crohns Colitis2019
29502561MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.Mayo Clin Proc2018
30062862Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2018
28829762Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.Br J Cancer2017
28218502Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.BJOG2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
29029385Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.Oncotarget2017
29049607Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.JAMA Oncol2017
26189026Mesalazine-induced eosinophilic pneumonia in a patient with ulcerative colitis disease: a case report and literature review.Int J Colorectal Dis2016
26463438The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.J Gynecol Oncol2016
27492892Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.EBioMedicine2016
25398451Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.Clin Cancer Res2015
26637920Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study.Anticancer Res2015
25454820Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.Mol Oncol2015
25581431Identification of six new susceptibility loci for invasive epithelial ovarian cancer.Nat Genet2015
24870930CUL4A contributes to the biology of basal-like breast tumors through modulation of cell growth and antitumor immune response.Oncotarget2014
23364677Analysis of DNA repair-related genes in breast cancer reveals CUL4A ubiquitin ligase as a novel biomarker of trabectedin response.Mol Cancer Ther2013
23935836Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.PLoS One2013
23558894DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas.Br J Cancer2013
23233066Phenotypic characterization of hereditary epithelial ovarian cancer based on a tissue microarray study.Histol Histopathol2013
22274685Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.JAMA2012
20037779Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer.Breast Cancer Res Treat2010
20461757High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma.Genes Chromosomes Cancer2010
20581869Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.Oncogene2010
18302019Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.Breast Cancer Res Treat2009
19995430Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.Breast Cancer Res2009
19737859Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.Carcinogenesis2009
19826428Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis.Br J Cancer2009
19190117Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells.Mol Cancer Ther2009
18270812Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.Breast Cancer Res Treat2009
18071313Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.Oncogene2008
18258506The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets.Clin Transl Oncol2008
  • 1 - 50 of 74

Recommended Authors

Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 4
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 50
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 7
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 3
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 2
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 30
Maryou B Lambros
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 4
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 8
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 6
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 12
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 5
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 69
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 4
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 3
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 7
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 1
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 4
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 5
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 37
James M Ford
Stanford University
Career Start Year 1989
Number of shared co-authors 12
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 101
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 7
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 7
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 9
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 110
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 92
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 6
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 3

Collaborators

Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 41
Ana Osorio
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 18
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 15
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 14
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 14
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 13
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 13
Anna DeFazio
Westmead Hospital
Co-authored papers 13
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 12
Jos?? Palacios
Universidad de Alcala
Co-authored papers 12
David G Huntsman
University of British Columbia
Co-authored papers 12
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 12
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 12
Stacey J Winham
Mayo Clinic
Co-authored papers 11
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 11
Weiva Sieh
Co-authored papers 10
Andrew Berchuck
Duke School of Medicine
Co-authored papers 10
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 10
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 10
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 10
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 10
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 9
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 9
Sandra Orsulic
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 9
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 9
Martin K??bel
University of Calgary
Co-authored papers 9
Sian Fereday
Peter MacCallum Cancer Centre
Co-authored papers 9
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 9
Alice S Whittemore
Co-authored papers 9
Michael E Carney
John A. Burns School of Medicine, University of Hawaii
Co-authored papers 9
Release 1.2